ReviewInternational journal of endocrinology and metabolism2019

Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review.

Soghra Rabizadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.